341 related articles for article (PubMed ID: 23968706)
1. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
[TBL] [Abstract][Full Text] [Related]
2. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
[TBL] [Abstract][Full Text] [Related]
3. Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing: A Comparative Drug-Coated Balloon Study in the Familial Hypercholesterolemic Swine Model of Superficial Femoral In-Stent Restenosis.
Gongora CA; Shibuya M; Wessler JD; McGregor J; Tellez A; Cheng Y; Conditt GB; Kaluza GL; Granada JF
JACC Cardiovasc Interv; 2015 Jul; 8(8):1115-1123. PubMed ID: 26117470
[TBL] [Abstract][Full Text] [Related]
4. Biological effect on restenosis and vascular healing of encapsulated paclitaxel nanocrystals delivered via coated balloon technology in the familial hypercholesterolaemic swine model of in-stent restenosis.
Cheng Y; Shibuya M; McGregor J; Conditt GB; Yi GH; Kaluza GL; Gray W; Doshi M; Sojitra P; Granada JF
EuroIntervention; 2016 Oct; 12(9):1164-1173. PubMed ID: 27753601
[TBL] [Abstract][Full Text] [Related]
5. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355
[TBL] [Abstract][Full Text] [Related]
6. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
Milewski K; Tellez A; Aboodi MS; Conditt GB; Yi GH; Thim T; Stenoien M; McGregor JC; Gray WA; Virmani R; Granada JF; Kaluza GL
EuroIntervention; 2011 Jul; 7(3):362-8. PubMed ID: 21729839
[TBL] [Abstract][Full Text] [Related]
8. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
[TBL] [Abstract][Full Text] [Related]
9. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF
EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis.
Milewski K; Afari ME; Tellez A; Aboodi MS; Kim JS; Cheng Y; Conditt GB; McGregor JC; Yi GH; Stenoien M; Langanki D; Krueger CG; Kaluza GL; Granada JF
JACC Cardiovasc Interv; 2012 Oct; 5(10):1081-8. PubMed ID: 23078739
[TBL] [Abstract][Full Text] [Related]
11. Biological effect of orbital atherectomy and adjunctive paclitaxel-coated balloon therapy on vascular healing and drug retention: early experimental insights into the familial hypercholesterolaemic swine model of femoral artery stenosis.
Tellez A; Dattilo R; Mustapha JA; Gongora CA; Hyon CM; Palmieri T; Rousselle S; Kaluza GL; Granada JF
EuroIntervention; 2014 Dec; 10(8):1002-8. PubMed ID: 25308298
[TBL] [Abstract][Full Text] [Related]
12. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
[TBL] [Abstract][Full Text] [Related]
13. Safety of Zilver PTX Drug-Eluting Stent Implantation Following Drug-Coated Balloon Dilation in a Healthy Swine Model.
Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
J Endovasc Ther; 2018 Feb; 25(1):118-126. PubMed ID: 29161933
[TBL] [Abstract][Full Text] [Related]
14. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
J Vasc Interv Radiol; 2018 Jul; 29(7):1041-1049.e3. PubMed ID: 29754850
[TBL] [Abstract][Full Text] [Related]
15. Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
Pavo N; Samaha E; Sabdyusheva I; von Strandmann RP; Stahnke S; Plass CA; Zlabinger K; Lukovic D; Jambrik Z; Pavo IJ; Bergler-Klein J; Gray WA; Maurer G; Gyöngyösi M
J Mater Sci Mater Med; 2016 Aug; 27(8):131. PubMed ID: 27388164
[TBL] [Abstract][Full Text] [Related]
16. Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
Bienek S; Kusmierczuk M; Mittag A; Bettink S; Scheller B
Catheter Cardiovasc Interv; 2020 Feb; 95(2):319-328. PubMed ID: 31696642
[TBL] [Abstract][Full Text] [Related]
17. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis.
Cremers B; Milewski K; Clever YP; Aboodi MS; Biedermann M; Thim T; Kelsch B; Kaluza GL; Scheller B; Granada JF
Catheter Cardiovasc Interv; 2012 Oct; 80(4):603-10. PubMed ID: 22511557
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
Yamamoto E; Watanabe S; Bao B; Watanabe H; Nakatsuma K; Izuhara M; Ono K; Nakazawa G; Kimura T; Saito N
Cardiovasc Revasc Med; 2018 Jun; 19(4):433-437. PubMed ID: 29174499
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
Kolodgie FD; Pacheco E; Yahagi K; Mori H; Ladich E; Virmani R
J Vasc Interv Radiol; 2016 Nov; 27(11):1676-1685.e2. PubMed ID: 27641674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
